Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-26

Clinical Trial Update: Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE). [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether an apomorphine pump improves sleep quality in Parkinson's disease patients, which was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apomorphine (apomorphine)

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: Parkinson's Disease | Phase 4 | Status: TERMINATED